ipf
Showing 26 - 50 of 558
Idiopathic Pulmonary Fibrosis Trial in Shanghai (Human umbilical cord mesenchymal stem cell injection)
Not yet recruiting
- Idiopathic Pulmonary Fibrosis
- Human umbilical cord mesenchymal stem cell injection
-
Shanghai, Shanghai, ChinaShanghai Sixth People's Hospital
Jul 29, 2022
Pulmonary Fibrosis Trial (A wearable cough monitoring device, the Strados Labs RESP?? sensor, with an accompanying mobile
Not yet recruiting
- Pulmonary Fibrosis
- A wearable cough monitoring device, the Strados Labs RESPᵀᴹ sensor, with an accompanying mobile application (App) for data collection
- (no location specified)
Jan 9, 2023
Functional MR Lung Imaging Using Hyperpolarised 129Xe
Completed
- COPD
- IPF
- hyperpolarised 129 Xenon
-
Nottingham, United KingdomHyperpolarised Imaging Lung Facility, QMC, Uni of Nottingham
Dec 21, 2022
Idiopathic Pulmonary Fibrosis (IPF)
Active, not recruiting
- Pulmonary Fibrosis
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh
Dec 13, 2022
Idiopathic Pulmonary Fibrosis Trial (Cudetaxestat (BLD-0409), Control: Matching Placebo)
Not yet recruiting
- Idiopathic Pulmonary Fibrosis
- Cudetaxestat (BLD-0409)
- Control: Matching Placebo
- (no location specified)
May 12, 2022
Idiopathic Pulmonary Fibrosis Trial in Hialeah Gardens (20mM sodium pyruvate nasal spray, Saline Placebo control nasal spray)
Recruiting
- Idiopathic Pulmonary Fibrosis
- 20mM sodium pyruvate nasal spray
- Saline Placebo control nasal spray
-
Hialeah Gardens, FloridaFamily First Medical Research Center
Sep 16, 2023
Idiopathic Pulmonary Fibrosis Trial (TTI-101, Placebo)
Not yet recruiting
- Idiopathic Pulmonary Fibrosis
- TTI-101
- Placebo
- (no location specified)
Jan 3, 2023
Interstitial Lung Disease, Obstructive Sleep Apnea Trial in New York (Auto-CPAP, Withdrawal of Auto-CPAP)
Recruiting
- Interstitial Lung Disease
- Obstructive Sleep Apnea
- Auto-CPAP
- Withdrawal of Auto-CPAP
-
New York, New YorkColumbia University Medical Center
Mar 25, 2022
Obstructive Sleep Apnea and Idiopathic Pulmonary Fibrosis
Recruiting
- OSA,IPF
- IL-17A,S100A8
-
Tianjin, ChinaTianjin Medical University General Hospital
Apr 20, 2023
Idiopathic Pulmonary Fibrosis, Cough Trial in India (ME-015 (Suplatast Tosilate), Identical )
Not yet recruiting
- Idiopathic Pulmonary Fibrosis
- Cough
- ME-015 (Suplatast Tosilate)
- Identical placebo
-
Guntur, Andhra Pradesh, India
- +3 more
Aug 1, 2023
Radiomics Algorithm for UIP Compared to Medical Doctors
Completed
- Idiopathic Pulmonary Fibrosis
- +2 more
- Radiomics model to classify between IPF with UIP pattern and ILDs without UIP pattern
-
Maastricht, Limburg, NetherlandsMaastricht University
Mar 14, 2023
Changes in iOS in IPF
Active, not recruiting
- Idiopathic Pulmonary Fibrosis
-
London, Gb-lnd, United KingdomRoyal Brompton and Harefield hospitals
May 4, 2022
IPF Trial (HNC1058 Capsules)
Not yet recruiting
- IPF
- HNC1058 Capsules
- (no location specified)
Apr 5, 2023
Idiopathic Pulmonary Fibrosis (IPF) Trial in Shanghai (ZSP1603, Placebo)
Recruiting
- Idiopathic Pulmonary Fibrosis (IPF)
- ZSP1603
- Placebo
-
Shanghai, Shanghai, ChinaShanghai Lung Hospital
Nov 3, 2021
Trends in Quality of Life in Idiopathic Pulmonary Fibrosis Under
Active, not recruiting
- Idiopathic Pulmonary Fibrosis
-
Alexandroupoli, Greece
- +9 more
Aug 22, 2022
Idiopathic Pulmonary Fibrosis, Idiopathic Interstitial Pneumonia, Interstitial Lung Diseases Trial in Worldwide (patient
Recruiting
- Idiopathic Pulmonary Fibrosis
- +3 more
- patient registry (observation and biomaterial sampling)
-
Vienna, Austria
- +6 more
Nov 2, 2021
IPF Trial (AMB-05X, Placebo)
Not yet recruiting
- IPF
- AMB-05X
- Placebo
- (no location specified)
Jul 27, 2022
Dyspnea and Idiopathic Pulmonary Fibrosis
Recruiting
- Pulmonary Fibrosis
-
Lille, FranceHop Calmette Chu Lille
Mar 28, 2022
Idiopathic Pulmonary Fibrosis (IPF) Trial in Manchester (TD-1058, Placebo)
Terminated
- Idiopathic Pulmonary Fibrosis (IPF)
- TD-1058
- Placebo
-
Manchester, United KingdomTheravance Biopharma Investigational Site
Feb 7, 2022
Idiopathic Pulmonary Fibrosis Trial in Seattle (12-week mHealth home exercise prescription)
Recruiting
- Idiopathic Pulmonary Fibrosis
- 12-week mHealth home exercise prescription
-
Seattle, WashingtonUniversity of Washington
Oct 4, 2021
Idiopathic Pulmonary Fibrosis (IPF) Trial in United States (Saracatinab, Placebo)
Recruiting
- Idiopathic Pulmonary Fibrosis (IPF)
- Saracatinab
- Placebo
-
Denver, Colorado
- +3 more
Jan 27, 2023
Idiopathic Pulmonary Fibrosis Trial (LTP001, Placebo, Standard of Care (SoC))
Not yet recruiting
- Idiopathic Pulmonary Fibrosis
- LTP001
- +2 more
- (no location specified)
Aug 10, 2022
Idiopathic Pulmonary Fibrosis Trial in San Francisco, Boston, New York (EGCG 300 mg + Nintedanib, EGCG 300 mg + Pirfenidone,
Not yet recruiting
- Idiopathic Pulmonary Fibrosis
- EGCG + Nintedanib
- +2 more
-
San Francisco, CaliforniaUCSF Parnassus
Apr 25, 2022
Idiopathic Pulmonary Fibrosis Trial in United States (ORIN1001, Placebo)
Recruiting
- Idiopathic Pulmonary Fibrosis
- ORIN1001
- Placebo
-
Palm Springs, California
- +11 more
Jul 7, 2022